Risk prediction for advanced neoplasia using longitudinal adherence measures to fecal immunochemical test-based colorectal cancer screening programs.
Autori:
de Jonge L, Riggi E, van Duuren LA, Toes-Zoutendijk E, Campari C, Sassatelli R, Arrigoni A, Orione L, Lansdorp-Vogelaar I, Senore C.
Rivista:
Prev Med 2023; 170: 107488. doi: 10.1016/j.ypmed.2023.107488. Online ahead of print. PMID: 36931473 (IF 4.018)